CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Clinical trial NCT03032406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03032406
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2022-05-17
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.